"I intend to work for the rest of my life for pediatric cancer. I am sure that this group of scientists will find the cure for medulloblastoma. And once we find the cure for this tumor, we will move on to another." This is the driving force behind MBI, as told by founder Fernando Goldsztein to journalist Eliane Trindade from the newspaper Folha de São Paulo.

We thank Folha de São Paulo and journalist Eliane Trindade for sharing our story at Folha Social+.

You can read the full story (in portuguese) here